Prophylactic Cervical Cerclage in Twin Pregnancies With Non-shortened Cervix
Primary Purpose
Preterm Birth, Twin Pregnancy, Antepartum Condition or Complication, Cervical Cerclage
Status
Recruiting
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
Cervical cerclage
Sponsored by
About this trial
This is an interventional prevention trial for Preterm Birth
Eligibility Criteria
Inclusion Criteria:
- Age between 18-50 years.
- Dichorionic twins.
- History of ≥1 preterm birth.
- Transvaginal sonographic cervical length is ≥25 mm at 14-20 weeks gestational age.
- Asymptomatic.
Exclusion Criteria:
- Triplets and quadruplets.
- Monochorionic twins.
- Threatened/ inevitable miscarriage
- Bulging membranes through the external os.
- Extremes of age.
- Major fetal anomalies.
- Known cases with uterine anomalies e.g. bicornuate uterus, uterus didelphis… etc.
- Fetal demise.
- Fetal reduction in the current pregnancy.
Sites / Locations
- Faculty of medicine, Zagazig UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Group A
Group B
Arm Description
cervical cerclage between 14 and 20 weeks will be done by one of the three authors. McDonald cervical cerclage.
Routine antenatal care without cerclage
Outcomes
Primary Outcome Measures
The incidence of preterm birth at ≤35+6, ≤33+6, and ≤31+6 weeks.
Number of preterm deliveries stratified according to gestational age groups mentioned
Secondary Outcome Measures
The incidence of miscarriage.
Number of missed, inevitable and complete miscarriage less than 20 weeks
Incidence of cervico-vaginal infection
Number of infections diagnosed by patient complaint, clinical examination and confirmed by culture and sensitivity
Incidences of bad Neonatal outcomes in both groups
Number of of neonates with respiratory distress, IVH, necrotizing enterocolitis, sepsis, NICU admission
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT05334264
Brief Title
Prophylactic Cervical Cerclage in Twin Pregnancies With Non-shortened Cervix
Official Title
The Value of Prophylactic Cervical Cerclage Against Preterm Birth in Twin Pregnancies With History of Preterm Birth and Non-shortened Cervix: A Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
July 2023
Overall Recruitment Status
Recruiting
Study Start Date
December 20, 2021 (Actual)
Primary Completion Date
September 28, 2023 (Anticipated)
Study Completion Date
October 15, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Zagazig University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This randomized controlled trial is aimed to assess the protective value of prophylactic cervical cerclage against preterm birth in twin pregnancies with history of one or more preterm births without having cervical shortening in the current pregnancy.
Detailed Description
Multiple pregnancies are high-risk pregnancies and usually associated with an increased risk of neonatal morbidity and mortality, mainly due to preterm births. Preterm births occur in 50% of twin pregnancies and the mean gestational age for delivery is 35.3 weeks. Ten percent of all twin births take place before 32 weeks of gestation.1 Preterm births are responsible for more than 70% of all neonatal and infant deaths.2 Prematurity can have serious consequences for the child, such as hearing difficulties, vision impairment, learning disabilities, reduced IQ, and cerebral palsy. A cervical length of ≤25 mm in twin pregnancies is a good predictor of a spontaneous preterm birth when measured around 24 weeks of gestation.3,4 Numerous interventions have been attempted in order to prevent preterm births in twin gestations, but until now, no intervention has been effective. Use of cerclage in twin pregnancies is controversial. Some experts claim that placing a cervical cerclage could increase the risk of preterm births5, Fuchs and Senat6 concluded that cervical cerclage in asymptomatic twins did not reduce the risk of PTB. This conclusion came depending on small sample sized randomized trail done on less than 50 patients.7 Available meta-analytic data remained of limited value in view of the few and small clinical studies that were included.
Although the current meta-analyses indicate the lack of efficacy of cerclage in twin pregnancies, data from the US Standard Certificate of Live Birth indicated that roughly 10% of triplets and 1.3% of twins are still receiving cerclage.8 Some authors compared the efficacy of cerclage in twin pregnancies and singleton pregnancies and showed that women with twin pregnancies who received cerclage might show beneficial obstetric outcomes similar to those of women with singleton gestations.9,10 Such practice is still in need for further validation by well-structured and powered randomized controlled trials.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Preterm Birth, Twin Pregnancy, Antepartum Condition or Complication, Cervical Cerclage
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
170 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Group A
Arm Type
Experimental
Arm Description
cervical cerclage between 14 and 20 weeks will be done by one of the three authors. McDonald cervical cerclage.
Arm Title
Group B
Arm Type
No Intervention
Arm Description
Routine antenatal care without cerclage
Intervention Type
Procedure
Intervention Name(s)
Cervical cerclage
Intervention Description
McDonald cervical cerclage will be applied using Mersaline braided tape with double needle. Single stitch (4 bites) will be applied as close as possible to the level of internal os. The Knot will be put either anterior or posterior according to the surgeon desire.
Primary Outcome Measure Information:
Title
The incidence of preterm birth at ≤35+6, ≤33+6, and ≤31+6 weeks.
Description
Number of preterm deliveries stratified according to gestational age groups mentioned
Time Frame
immediately after delivery for study cases through study completion, an average of 1 year
Secondary Outcome Measure Information:
Title
The incidence of miscarriage.
Description
Number of missed, inevitable and complete miscarriage less than 20 weeks
Time Frame
immediately after occurrence of miscarriage through study completion, an average of 1 year
Title
Incidence of cervico-vaginal infection
Description
Number of infections diagnosed by patient complaint, clinical examination and confirmed by culture and sensitivity
Time Frame
once reported or confirmed during pregnancy through study completion, an average of 1 year
Title
Incidences of bad Neonatal outcomes in both groups
Description
Number of of neonates with respiratory distress, IVH, necrotizing enterocolitis, sepsis, NICU admission
Time Frame
during early neonatal follow up through study completion, an average of 1 year
10. Eligibility
Sex
Female
Gender Based
Yes
Gender Eligibility Description
Pregnant ladies
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Age between 18-50 years.
Dichorionic twins.
History of ≥1 preterm birth.
Transvaginal sonographic cervical length is ≥25 mm at 14-20 weeks gestational age.
Asymptomatic.
Exclusion Criteria:
Triplets and quadruplets.
Monochorionic twins.
Threatened/ inevitable miscarriage
Bulging membranes through the external os.
Extremes of age.
Major fetal anomalies.
Known cases with uterine anomalies e.g. bicornuate uterus, uterus didelphis… etc.
Fetal demise.
Fetal reduction in the current pregnancy.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Hytham Atia
Phone
+966538308500
Email
hythamatia@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Amro El Nemr
Organizational Affiliation
Zagazig University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Mohamed Lashin
Organizational Affiliation
Zagazig University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Faculty of medicine, Zagazig University
City
Zagazig
State/Province
Sharkia
ZIP/Postal Code
44519
Country
Egypt
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Hytham Atia, M.D.
Email
hythamatia@gmail.com
First Name & Middle Initial & Last Name & Degree
Amro El Nemr, M.D.
First Name & Middle Initial & Last Name & Degree
Mohamed Lashin, M.D.
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Prophylactic Cervical Cerclage in Twin Pregnancies With Non-shortened Cervix
We'll reach out to this number within 24 hrs